The largest database of trusted experimental protocols

12 protocols using srankl

1

Osteoclast Precursor Cell Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The osteoclast precursor cell line, 4B12 [4 (link)], was maintained in α-Eagle's Minimum Essential Medium (α-MEM) containing 10% fetal bovine serum (FBS) and 30% calvaria-derived stromal cell conditioned media (CSCM) [4 (link)]. RAW264.7D clone cells were maintained in α-MEM containing 10% FBS [6 (link)]. Bone marrow cells were obtained by flushing the femurs of 6-week-old DDY male mice. For the formation of M-BMMs, stromal cells free bone marrow cells were cultured in the presence of M-CSF (10 ng/ml) for 7 days. M-BMMs were suspended in α-MEM containing 10% FBS, and used for various experiments. The ERK5 pathway inhibitors BIX02189 (MEK5 inhibitor) and XMD8-92 (ERK5 inhibitor) were purchased from Selleck Chemicals (Houston, TX) and MedChemexpress (Princeton, NJ), respectively. Mouse M-CSF (mM-CSF) and sRANKL were obtained from R&D Systems (Pittsburgh, PA).
+ Open protocol
+ Expand
2

Quantifying Osteoclast Progenitors in Bone Marrow

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify osteoclast progenitor cells, bone marrow (BM) was flushed out from long bones of 3 mice for each genotype and plated in triplicates at a density of 50,000 cells/cm2 in 48 well plates. After 4–5 days of culture in α-MEM medium (Invitrogen), supplemented with 10% FBS, 1% PSG, 30 ng/ml M-CSF, and 30 ng/ml sRANKL (R&D Systems) the cells in the plate were fixed with 10% neutral buffered formaldehyde for 15 min and osteoclasts detected by staining for TRAP. Non adherent BM cells depleted of stromal cells were used for the rest of culture experiments.
+ Open protocol
+ Expand
3

RAW264.7 Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264.7 cell lines were purchased from American Type Culture Collection (ATCC, CRL-1446) (Rockville, MD). All reagents used were ACS or MB grade. sRANKL and mCSF recombinant mouse proteins were purchased from R&D Systems (Minneapolis, MN).
+ Open protocol
+ Expand
4

Recombinant Signaling Protein Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
WNT3A, Dickkopf-related protein 1 (DKK1), macrophage colony-stimulating factor (M-CSF), and soluble Receptor activator of nuclear factor kappa-B ligand (sRANKL) recombinant proteins were purchased from R&D Systems (Minneapolis, MN).
+ Open protocol
+ Expand
5

Isolation and Culture of Osteoclast Precursors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were isolated from both femurs, tibias, and pelvic bones by cutting the epiphyses, flushing the bones with αMEM media using a 26G needle, and passing through a 70μm cell strainer. Red blood cells were removed using RBC Lysis Buffer (Invitrogen). The bone marrow cells were then resuspended in αMEM media containing 10% FBS and 1% penicillin-streptomycin and kept on ice. Cells were stained for surface markers as described above (methodssection 2.7.) and were sorted using a BD FACS Aria II SORP. Sufficient numbers of osteoclast precursor Population VI were acquired from each mouse and were used for in vitro osteoclast formation assays. Equal number of cells (1.2×104 cells/well) were seeded in a 48-well dish in αMEM media containing 10% FBS, 1% penicillin-streptomycin, 30 ng/ml M-CSF (Peprotech; #315–02), and 50 ng/ml sRANKL (R&D Systems; #462-TEC) for 3 and 5 days at 37°C in 5% CO2. Medium was refreshed every other day. The cells were stained with TRAP (Sigma) and the number of TRAP+ mature osteoclasts (≥3 nuclei) per well were quantified after 3 and 5 days of culture. No distinction was made between large and small osteoclasts. Two wells per biological replicate were used for osteoclast formation assays.
+ Open protocol
+ Expand
6

Osteoclastogenic Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated BMMs were seeded at a density of 8 × 104 cells/well of a 24-well plate and in the presence of either 30 ng/mL M-CSF (Peprotech; #315–02) alone or M-CSF (30 ng/mL) and 50 ng/mL sRANKL (R&D Systems; #462-TEC) for 3 and 5 days at 37°C in 5% CO2. Total RNA was isolated from cells using TRIzol (Invitrogen) according to the manufacturer’s instructions. First-strand cDNA was synthesized with oligo(dT) and random primers using qScript cDNA SuperMix (Quantabio). All qRT-PCR were performed on an Analytik Jena qTower3 G Real-Time PCR Detection System using Applied Biosystems PowerUp SYBR Green master mix. Amplicon authenticity was confirmed by melt curve analysis. Primer sequences are provided in Supplementary Table 1 and β-actin was used as the normalization control. The data were analyzed for fold change using the ΔΔCT method.
+ Open protocol
+ Expand
7

In Vitro Bone Resorption Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To observe bone resorption in vitro, BMMs were cultured in Corning Osteo Assay Surface 96‐well Multiple Well Plates (Sigma) with 30 ng/mL M‐CSF and 75 ng/mL sRANKL (R&D Systems) or isolated RANKL for 6 days. Then, the plates were washed with pure water.
+ Open protocol
+ Expand
8

Modulation of Osteoclast Differentiation by TRPV4

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW 264.7 cells were cultured with high-glucose Dulbecco’s modified Eagle’s medium (DMEM, Hyclone, South Logan, UT, USA) containing 10% FBS (Hyclone) and 100 U/mL of penicillin/streptomycin (Thermo Fisher Scientific). A total of 5 × 103/well RAW264.7 cells at passages 3 to 5 were seeded into 24-well plates and induced by M-CSF (Peprotech, Cranbury, NJ, USA) and sRANKL (R&D Systems) at a concentration of 20 ng/mL for osteoclast differentiation. Human DPSC-derived exosomes were administrated with a final concentration of 5 × 107/mL.
To investigate the influence of TRPV4, the RAW 264.7 cells induced by M-CSF and sRANKL were treated with GSK219 (10 μM; Selleck, Houston, TX, USA), a specific TRPV4 inhibitor [46 (link)]. TRPV4 agonist GSK101 (Selleck Selleck, Houston, TX, USA) was delivered at a concentration of 100 nM [37 (link)]. DMSO was administrated as a control.
+ Open protocol
+ Expand
9

Murine Osteoclast Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were flushed from the femurs of 6‐week‐old female C57BL/6 mice, cultured in alpha‐MEM containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific Inc. Waltham, MA, USA) and 30 ng/mL M‐CSF (R&D systems, Minneapolis, MN, USA) after treatment with RBC lysis buffer (Gibco, Gaithersburg, MD, USA). After incubation for 3 days, supernatant cells were removed. Adherent cells were used for BMMs. Then, osteoclast differentiation was induced by adding 30 ng/mL M‐CSF and 75 ng/mL sRANKL (R&D Systems) or isolated RANKL for 4 days. Multinucleated cells were stained using a TRAP assay kit (KAMIYA BIOMEDICAL Co., Seattle, WA, USA), and TRAP‐positive cells with more than five nuclei were identified as osteoclasts.
+ Open protocol
+ Expand
10

Osteogenesis and Osteoclastogenesis Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs was grown in αMEM (Gibco, Carlsbad, CA, USA) and contained 10 % FBS. MLO-A5 was grown in αMEM (Gibco, Carlsbad, CA, USA) and contained 5 % FBS and 5 % fetal calf serum. For osteogenesis differentiation, MSCs and MLO-A5s were treated with 500 μM ascorbic acid, 10 mM β-glycerophosphate, and 100 nM dexamethasone.
For osteoclasts differentiation, bone marrow-derived mononuclear cells (BMMs), isolated from the tibiae of 6-week-old male C57 mice, were cultured for 7 days in α-MEM supplemented with 10 % FBS and M-CSF (30 ng/ml, R&D). The cells were subsequently passaged and further cultured with M-CSF (30 ng/ml) and sRANKL (50 ng/ml, R&D) for approximately 5–7 days until multinucleated cell fusion was observed. Conditioned media from MSC-C (MSC-C-CM) or MSC-E4 (MSC-E4-CM) were added to the cultures at a 1:100 dilution in α-MEM. For TRAP staining, cells were fixed and stained to identify TRAP-positive multinucleated cells, which, possessing more than three nuclei, were quantified as osteoclasts based on size and number. Concurrently, mRNA was extracted to quantify genes associated with osteoclast differentiation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!